Skip to main content

Advertisement

Log in

Fluoride treatment for osteoporosis

  • Editorials
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Heaney R, Baylink D, Johnston C, Melton LJ, Meunier P, Murray T, Nagant de Deuxchaisnes C (1989) Fluoride therapy for vertebral crush fracture syndrome. A status report. Annal Intern Med 111:678–680

    CAS  Google Scholar 

  2. Pak CYC, Sakhaee K, Zerwekh JE, Parcel C, Peterson R, Johnson K (1989) Safe and effective treatment of osteoporosis with intermittent slow release sodium fluoride: augmentation of vertebral bone mass and inhibition of fractures. J Clin Endocrinol Metab 68:150–159

    Article  PubMed  CAS  Google Scholar 

  3. Mamelle N, Dusan R, Martin JI, Meunier PJ, Gauillaume M, Faucher A, Zeigler G. Risk-benefit ratio of sodium fluoride treatment in primary vertebral osteoporosis, Lancet 361–365, 1988

  4. Riggs BL, Hodgson SF, Wahner H, Muhs J, O'Fallon WM. Effect of long-term fluoride therapy in bone metabolism, bone density, and fracture rate in Type 1 (postmenopausal) osteoporosis: final results of prospective, controlled, double-blind Clinical Trial. Presented at Joint Meeting of ICCRH and ASBMR, September 13, 1989, Montreal, Canada

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Harrison, J.E. Fluoride treatment for osteoporosis. Calcif Tissue Int 46, 287–288 (1990). https://doi.org/10.1007/BF02563816

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02563816

Navigation